ESPR
Esperion Therapeutics Inc
3.20$
+0.0%
vs. previous close
Closing price · As of: Jul 15, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | 26.8% | 31.8% | 4,357.2% | 4,921.6% | 3,893.5% | 1.7% | 0.2% | 7.2% | 17.5% | 22.4% | 4.4% | 38.6% | 33.0% | 37.8% | 48.7% | 34.3% | 22.1% | 47.9% | 26.3% | 39.4% | 35.5% | 7.3% | 21.1% | 33.5% | 37.1% | 48.5% | 34.6% | 63.5% | 16.5% | 43.2% | 35.0% | |
| – | – | – | – | – | – | – | – | – | – | 73.2% | 68.2% | -4,257.2% | -4,821.6% | -3,793.5% | 98.3% | 99.8% | 92.8% | 82.5% | 77.6% | 95.6% | 61.4% | 67.0% | 62.2% | 51.3% | 65.7% | 77.9% | 52.1% | 73.7% | 60.6% | 64.5% | 92.7% | 78.9% | 66.5% | 62.9% | 51.5% | 65.4% | 36.5% | 83.5% | 56.8% | 65.0% | |
| – | – | – | – | – | – | – | – | – | – | 26.8% | 31.8% | 4,357.2% | 4,921.6% | 3,893.5% | 1,886.0% | 16.5% | 920.5% | 435.4% | 350.4% | 61.7% | 175.8% | 179.3% | 129.1% | 172.1% | 153.5% | 175.5% | 129.0% | 85.7% | 43.8% | 55.0% | 9.7% | 15.5% | 20.1% | 15.9% | 19.3% | 8.8% | 16.2% | 8.3% | 11.2% | 10.6% | |
| – | – | – | – | – | – | – | – | – | – | 6.1% | 8.4% | 1,373.9% | 1,882.6% | 2,211.0% | 2,258.3% | 22.5% | 1,273.8% | 431.1% | 787.8% | 113.9% | 311.1% | 160.0% | 199.1% | 205.9% | 131.5% | 68.2% | 170.8% | 158.0% | 97.9% | 92.5% | 30.5% | 59.8% | 77.4% | 16.5% | 66.2% | 48.0% | 47.9% | 24.6% | 53.8% | 39.7% | |
| – | – | – | – | – | – | – | – | – | – | 32.9% | 40.2% | 5,731.2% | 6,804.2% | 6,104.5% | 4,144.3% | 39.0% | 2,194.3% | 1,074.1% | 1,115.8% | 175.6% | 448.3% | 428.2% | 290.4% | 329.3% | 285.0% | 303.8% | 251.9% | 217.4% | 141.7% | 195.9% | 40.2% | 75.4% | 97.6% | 69.3% | 85.5% | 56.7% | 47.9% | 32.9% | 65.1% | 46.9% | |
| – | – | – | – | – | – | – | – | – | – | -32.9% | 59.8% | -5,631.2% | -6,704.2% | -6,004.5% | -4,046.0% | 60.9% | -2,101.5% | -991.6% | -1,038.2% | -80.0% | -386.9% | -361.2% | -228.2% | -278.0% | -219.3% | -225.9% | -199.8% | -143.7% | -81.1% | -131.4% | 52.5% | 3.5% | -31.0% | -6.4% | -34.0% | 8.6% | -11.4% | 50.6% | -8.2% | 18.1% | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | 2.7% | 406.9% | 407.3% | 420.0% | 226.7% | 2.2% | 128.6% | 92.7% | 101.8% | 27.4% | 94.8% | 87.2% | 74.7% | 75.7% | 74.6% | 76.1% | 59.1% | 56.4% | 44.1% | 46.7% | 10.2% | 18.6% | 29.2% | 23.8% | 29.9% | 24.9% | 25.3% | 13.4% | 24.7% | 20.3% | |
| – | – | – | – | – | – | – | – | – | – | -32.5% | 60.1% | -5,521.5% | -6,970.1% | -6,308.1% | -4,252.7% | 58.7% | -2,229.0% | -1,084.0% | -1,139.8% | -107.4% | -481.5% | -422.8% | -301.2% | -352.0% | -290.4% | -294.9% | -253.7% | -193.7% | -121.4% | -174.7% | 44.3% | -83.9% | -57.2% | -30.8% | -62.2% | -15.4% | -35.9% | 37.8% | -31.5% | -1.3% | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | – | – | 548.7% | 526.0% | 246.7% | 2.2% | 129.7% | 91.3% | 102.0% | 27.4% | 94.9% | 87.2% | 73.0% | 74.0% | 71.1% | 68.9% | 113.0% | -0.2% | -0.1% | -85.0% | 0.0% | – | -57.2% | – | – | – | – | 1.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -32.5% | 60.1% | -5,521.5% | -6,970.1% | -6,308.1% | -4,252.7% | 58.7% | -2,229.0% | -1,084.0% | -1,139.8% | -107.4% | -481.5% | -422.8% | -301.2% | -352.0% | -290.4% | -294.9% | -253.7% | -193.7% | -121.4% | -174.7% | 44.3% | -83.9% | -57.2% | -30.8% | -62.2% | -15.4% | -35.9% | 36.7% | -31.5% | -1.8% | |
| – | – | – | – | – | – | – | – | – | – | -32.5% | 59.8% | -5,515.9% | -6,553.4% | -5,877.9% | -4,020.2% | 61.0% | -2,096.2% | -989.7% | -1,036.1% | -79.6% | -385.7% | -334.6% | -225.7% | -275.5% | -215.3% | -218.2% | -194.2% | -137.1% | -77.2% | -128.0% | 54.5% | -65.3% | -27.9% | -7.0% | -32.3% | 9.5% | -10.6% | 51.3% | -56.1% | 9.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.